ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko05033	Nicotine addiction	8/63	56/7206	2.2076671841e-08
ko04721	Synaptic vesicle cycle	7/63	80/7206	5.34741236901e-06
ko04723	Retrograde endocannabinoid signaling	9/63	175/7206	1.83229191609e-05
ko04728	Dopaminergic synapse	8/63	185/7206	0.000187738011797
ko04727	GABAergic synapse	6/63	110/7206	0.000369793562261
ko04024	cAMP signaling pathway	9/63	279/7206	0.000647378758852
ko04713	Circadian entrainment	6/63	136/7206	0.00113750459771
ko04724	Glutamatergic synapse	6/63	152/7206	0.00201325191587
ko05032	Morphine addiction	5/63	110/7206	0.00263168227254
ko04080	Neuroactive ligand-receptor interaction	10/63	423/7206	0.00338125845246
ko04911	Insulin secretion	5/63	117/7206	0.0034384388313
ko00604	Glycosphingolipid biosynthesis - ganglio series	2/63	14/7206	0.00639796792323
ko04020	Calcium signaling pathway	7/63	265/7206	0.00800377741592
ko05031	Amphetamine addiction	4/63	91/7206	0.00803852877445
ko05030	Cocaine addiction	3/63	73/7206	0.0256776030733
ko05014	Amyotrophic lateral sclerosis (ALS)	3/63	74/7206	0.02659930893
ko04014	Ras signaling pathway	6/63	279/7206	0.0342617723948
ko04970	Salivary secretion	3/63	95/7206	0.0499739788446